Andere Sprachen Arecor Therapeutics plc

Aktien

A3CRY2

GB00BMWLM973

AREC

Markt geschlossen - London S.E. Andere Börsenplätze 17:35:05 26.04.2024			% 5 Tage	% 1. Jan.
136,5 ^GBX	0,00 %		+6,23 %	-25,21 %

23.04.	Finanzchef von Arecor verlässt das Unternehmen im Juli nach fünf Jahren	AN
23.04.	Arecor Therapeutics plc gibt den Rücktritt von Susan Lowther als Company Secretary und als Board Director mit Wirkung zum 22. Juli 2024 bekannt	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Arecor chief financial officer to leave in July after five years	23.04.
Arecor Therapeutics CFO to Leave in July	23.04.
Arecor Therapeutics plc Announces Stepping Down of Susan Lowther as Chief Financial Officer, Effective from July 22, 2024	23.04.
Arecor Therapeutics plc Announces Stepping Down of Susan Lowther as Company Secretary and as A Board Director, Effective from July 22,2024	23.04.
Arecor Therapeutics announces collaboration on oral GLP-1 drug for diabetes and obesity treatment	14.03.
Arecor to develop "holy grail" diabetes treatment with partner TRx	12.03.
ARECOR AND TRx BIOSCIENCES ESTABLISH RESEARCH COLLABORATION TO DEVELOP ORAL GLP-1 WITH ENHANCED BIOAVAILABILITY	12.03.
Arecor Therapeutics plc and Trx Biosciences Limited Announces Research Collaboration for the Formulation Development of an Oral GLP-1 Receptor Agonist Product	12.03.
EARNINGS AND TRADING: East Star, Getech strike Kazakhstan JV	29.02.
Arecor Therapeutics hails Arestat as 2023 performance "strong"	01.02.
Arecor pleased as investee Inhibrx sells therapy to Sanofi	23.01.
Patent boosts for DG Innovate and Arecor Therapeutics	18.01.
Arecor Therapeutics Gains European Patent for Insulin Product Formulations	18.01.
Arecor expands speciality hospital collaboration with partner	08.01.
Arecor Therapeutics Expands Formulation Study Collaboration with Pharmaceutical Partner	08.01.
Arecor Therapeutics plc Expands Ongoing, Exclusive Formulation Study Collaboration with the Pharmaceutical Division of One of the World's Largest Chemicals Marketing and Pharmaceuticals Companies	08.01.
Arecor Therapeutics reveals deal with "global medical products company"	05.12.
Arecor inks co-development deal with global medical company	04.12.
Arecor Therapeutics Signs Exclusive License Option Agreement for Oncology Product	04.12.
Arecor Therapeutics plc Announces Co-Development and Exclusive Licence Option Agreement	04.12.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Arecor Therapeutics plc

Aktien

A3CRY2

GB00BMWLM973

AREC

Andere Sprachen

Filter